{"id":76394,"date":"2018-02-27T05:42:28","date_gmt":"2018-02-27T13:42:28","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2018\/02\/all-star-team-of-synthetic-biologists-raise-53-million-for-cancer-therapy-startup-senti"},"modified":"2018-02-27T05:42:28","modified_gmt":"2018-02-27T13:42:28","slug":"all-star-team-of-synthetic-biologists-raise-53-million-for-cancer-therapy-startup-senti","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2018\/02\/all-star-team-of-synthetic-biologists-raise-53-million-for-cancer-therapy-startup-senti","title":{"rendered":"All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/all-star-team-of-synthetic-biologists-raise-53-million-for-cancer-therapy-startup-senti.jpg\"><\/a><\/p>\n<p>A who\u2019s-who from the world of synthetic biological research have come together to launch <a target=\"_blank\" href=\"http:\/\/sentibio.com\" rel=\"noopener\">Senti Biosciences<\/a> with $53 million in funding from a slew of venture capital investors.<\/p>\n<p>Led by Tim Lu, a longtime researcher at the Massachusetts Institute of Technology and one of the founding fathers of synthetic biology, Senti\u2019s aim is nothing less than developing therapies that are tailored to an individual\u2019s unique biology \u2014 and their first target is cancer.<\/p>\n<p>Here\u2019s how Lu described a potential cancer treatment using Senti\u2019s technology to me. \u201cWe take a cell derived from humans that we can insert our genetic circuits into\u2026 we insert the DNA and encoding and deliver those cells via an IV infusion. We have engineered the cells to locate where the tumors are\u2026 What we\u2019ve been doing is engineering those cells to selectively trigger an immune response against the tumor.\u201d<\/p>\n<p><!-- Link: <a href=\"https:\/\/techcrunch.com\/2018\/02\/27\/all-star-team-of-synthetic-biologists-raise-53-million-for-cancer-therapy-startup-senti\/?ncid=rss&utm_source=feedburner&utm_medium=feed&utm_campaign=sfgplus&sr_share=googleplus&%3Fncid=sfgplus\">https:\/\/techcrunch.com\/2018\/02\/27\/all-star-team-of-synthetic...id=sfgplus<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A who\u2019s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a longtime researcher at the Massachusetts Institute of Technology and one of the founding fathers of synthetic biology, Senti\u2019s aim is nothing less [\u2026]<\/p>\n","protected":false},"author":354,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1902,11,45,412],"tags":[],"class_list":["post-76394","post","type-post","status-publish","format-standard","hentry","category-bioengineering","category-biotech-medical","category-finance","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/76394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/354"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=76394"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/76394\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=76394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=76394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=76394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}